
Multiple Myeloma Hub
@mm_hub
An online educational resource run in collaboration with the European School of Haematology @ESHaematology linktr.ee/MultipleMyelom… #mmsm #myeloma
ID: 857866557778743296
http://www.multiplemyelomahub.com 28-04-2017 07:58:20
6,6K Tweet
9,9K Takipçi
2,2K Takip Edilen

CONGRESS | #EHA2025 | POSTER Fredrik Schjesvold, Fredrik Schjesvold, OsloMyelomaCenter presents updated results from the phase 1/2 CA057-003 trial of mezigdomide (MEZId) in RRMM (N=56). No new safety signals were identified across all cohorts. ORR - MEZId+TAM: 50%; MEZId+BMS-986158: 35%;
